Abstract

Braz J Med Biol Res, July 2010, Volume 43(7) 694-696

Human papillomavirus detection and p16 methylation pattern in a case of esophageal papilloma

L.A. Afonso, N. Moysés and Correspondence and Footnotes S.M.B. Cavalcanti

Laboratório de Diagnóstico Virológico, Departamento de Microbiologia e Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Niterói, RJ, Brasil

^Text

Correspondence and Footnotes ^{Correspondence and Footnotes} Correspondence and Footnotes

Abstract

Esophageal cancer is a prevalent cancer worldwide. Some studies have reported the possible etiology of human papillomavirus (HPV) in benign and malignant papillomas of the esophagus but the conclusions are controversial. In the present study, we investigated an esophageal papilloma from a 30-year-old male patient presenting aphasia. HPV DNA was detected by generic PCR using MY09/11 primers, and restriction fragment length polymorphism revealed the presence of HPV54, usually associated with benign genital lesions. Hypermethylation of the pINK4A gene was also investigated due to its relation to malignant transformation, but no modification was detected in the host gene. Except for an incipient reflux, no risk factors such as cigarette smoking, alcohol abuse or an infected sexual partner were recorded. Since esophageal lesions may have a malignant potential, HPV detection and typing are useful tools for patient follow-up.

Key words: Human papillomavirus; Esophageal cancer; Restriction fragment length polymorphism

Text

Esophageal cancer is the sixth most prevalent cancer worldwide, with a wide variation in incidence in different geographical regions of the world (1). An etiologic role of different microorganisms has been proposed for the pathogenesis of esophageal cancer such as fungus, bacteria, and viruses. Among the latter, are human papillomavirus (HPV), cytomegalovirus and Epstein-Barr virus. Several studies have reported the presence of HPV DNA in benign squamous cell papillomas (SCPs) of the esophagus (2-4). Esophageal squamous papillomas (ESPs) are uncommon benign lesions, usually asymptomatic and often discovered as incidental findings. The role of HPV in these benign lesions is controversial, with a wide variation in prevalence ranging from 0 to 100% having been reported in several studies (5). As suggested by Odze et al. (6), the detection of HPV in ESPs may be of a great value in terms of the follow-up of lesions associated with genotypes implicated in the genesis of premalignant and malignant lesions in squamous epithelial-lined tissues, including the nasal cavity, pharynx and anogenital tract. Because of the rarity of esophageal SCPs, the number of cases is still too small to draw definite conclusions about the role of HPV in their etiology. Syrjänen (1) published an extensive review of all cases reported and was the first to suggest the association of HPV with both benign and malignant squamous cell lesions of the esophagus. Only 30 reports on the subject are available in the literature and none from Brazil, although our country represents a high risk area for the development of esophageal squamous cell carcinoma (ESCC). Some investigators have suggested that HPV infection is frequently associated with ESCC in patients from geographic regions presenting a high incidence of ESCC, such as parts of China, South Africa and Iran (7-9).

In the present investigation, we studied an esophageal papilloma from a 30-year-old male patient with a 20-year history of hoarseness as well as swallowing difficulty. The patient was submitted to surgical extraction of the papilloma, which was then evaluated by histopathology and HPV detection by PCR. Intermittent reflux associated with progressive aphasia was the indication for endoscopy, which revealed an esophageal papilloma in the upper third of the esophagus, characterized as a polypoid, soft, smooth, whitish-pink tumor, measuring 6 mm in its largest dimension. Histopathological analysis revealed superficial acanthotic epithelial hyperplasia and papillomatosis with cytopathic alterations suggesting viral involvement, mainly koilocytosis. For HPV evaluation, DNA was extracted with the QiAmp Viral Kit for paraffin-embedded tissues (Qiagen, Germany). HPV DNA was detected by generic PCR using MY09/11 primers, as described elsewhere (10). HPV was then typed by restriction fragment length polymorphism (RFLP) as described by Bernard et al. (11) using a panel of six restriction enzymes (BamHI, DdeI, HaeIII, HinfI, PstI, RsaI). After 3% agarose gel electrophoresis, the RFLP results showed the presence of HPV54 (Figure 1), usually associated with benign genital lesions (12). We also tested the methylation status of the p16 gene from a DNA sample as described by House et al. (13). Briefly, DNA was modified with 3 M sodium bisulfite and 10 mM hydroquinone and the p16 gene was amplifed by the methylation-specific PCR technique. Two primer pairs (p16U and p16M) were used to distinguish methylated from unmethylated DNA in bisulfite-modified DNA.

Although presenting a low risk of malignant transformation, persistent HPV infection can lead to cancer. It is interesting to note that HPV54 was reported to be associated with HPV6 in a verrucous penile carcinoma (14). Nevertheless, it is still characterized as a low-risk virus (12) and DNA sequencing showed a poor relationship with the HPV16 genome (14).

Few studies have been conducted concerning the role of HPV in malignancy of the esophageal mucosa but the malignant potential of ESPs is still a matter of controversy (15). According to Talamini et al. (4), ESPs do not seem to involve a risk of development of malignancy or to be a marker of such risk. Bohn et al. (5) found a predominance of HPV infection by low-risk types and, in two cases, by high-risk types; however, no dysplastic changes, malignant transformation or recurrence were identified. Syrjänen (1) reported that, similarly to cervical cancer development, there are no doubts that ESCC develops through distinct precursor lesions, namely ESPs, but no prospective follow-up study has been published until now. In addition, the detection of HPV DNA in normal esophageal epithelium has been reported (16,17). Several risk factors have been proposed, such as cigarette smoking, alcohol abuse, smoked and hot food, and HPV infection in sexual partners, suggesting a multifactorial pathology (18).

Animal models have been developed in order to investigate such multi-factorial process. The most relevant one is related to esophageal carcinomas, common cancers associated with bovine papillomavirus 4 (BPV-4). Although BPV-4 causes benign lesions that usually regress spontaneously, the presence of carcinogenic co-factors can lead to malignant transformation. Among them, bracken fern diets are the best studied factor (19). Dietary carcinogens have already been described in humans, especially smoked and hot food (5). However, no direct relationship has been demonstrated between gastrointestinal tumors and HPV types and further studies are required to elucidate it. In the present study, except for an incipient reflux, no risk factor was recorded: the patient was not a cigarette smoker or alcohol addict and his sexual partner had no history of HPV infection, although regularly submitting to annual cytopathological screening. Recently, epigenetic modifications of pINK4A by hypermethylation, as well as p16 protein overexpression, have been implicated in cancer development (5). Nevertheless, our results pointed to an unmethylated host DNA (Figure 2). The benign features of the studied lesion would in fact predict a good prognosis for the patient.

Hence, we suggest that clinical and endoscopic follow-up be recommended for patients with a history of recurrent lesions showing HPV infection, mainly those caused by high-risk types, which have been demonstrated by numerous epidemiologic and molecular studies to be the etiologic agents for an overwhelming majority of premalignant and malignant cervical cases (18). In conclusion, HPV should be considered to be a risk factor for esophageal carcinoma.

References

1. Syrjänen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002; 55: 721-728.

2. Syrjänen K, Pyrhönen S, Aukee S, Koskela E. Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus. Diagn Histopathol 1982; 5: 291-296.

3. Mosca S, Manes G, Monaco R, Bellomo PF, Bottino V, Balzano A. Squamous papilloma of the esophagus: long-term follow up. J Gastroenterol Hepatol 2001; 16: 857-861.

4. Talamini G, Capelli P, Zamboni G, Mastromauro M, Pasetto M, Castagnini A, et al. Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. Int J Cancer 2000; 86: 874-878.

5. Bohn OL, Navarro L, Saldivar J, Sanchez-Sosa S. Identification of human papillomavirus in esophageal squamous papillomas. World J Gastroenterol 2008; 14: 7107-7111.

6. Odze R, Antonioli D, Shocket D, Noble-Topham S, Goldman H, Upton M. Esophageal squamous papillomas. A clinicopathologic study of 38 lesions and analysis for human papillomavirus by the polymerase chain reaction. Am J Surg Pathol 1993; 17: 803-812.

7. Chang F, Syrjanen S, Shen Q, Wang L, Wang D, Syrjanen K. Human papillomavirus involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques. Scand J Gastroenterol 1992; 27: 553-563.

8. Toh Y, Kuwano H, Tanaka S, Baba K, Matsuda H, Sugimachi K, et al. Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer 1992; 70: 2234-2238.

9. Turner JR, Shen LH, Crum CP, Dean PJ, Odze RD. Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum Pathol 1997; 28: 174-178.

10. Cavalcanti SMB, Oliveira LHS. Epidemiological aspects of human papillomavirus infection in the female genital tract. Virus Rev Res 2003; 8: 42-47.

11. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170: 1077-1085.

12. Agorastos T, Lambropoulos AF, Sotiriadis A, Mikos T, Togaridou E, Emmanouilides CJ. Prevalence and distribution of high-risk human papillomavirus in Greece. Eur J Cancer Prev 2009; 18: 504-509.

13. House MG, Guo M, Iacobuzio-Donahue C, Herman JG. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Carcinogenesis 2003; 24: 193-198.

14. Favre M, Kremsdorf D, Jablonska S, Obalek S, Pehau-Arnaudet G, Croissant O, et al. Two new human papilomavirus types (HPV54 and 55) characterized from genital tumours illustrate the plurality of genital HPVs. Human Cancer 1989; 4: 34-45.

15. Woo YJ, Yoon HK. In situ hybridization study on human papillomavirus DNA expression in benign and malignant squamous lesions of the esophagus. J Korean Med Sci 1996; 11: 467-473.

16. Chang F, Syrjänen S, Shen Q. Detection of HPV DNA in esophageal squamous cell carcinoma from the high-incidence area of Linxian, China. Scand J Gastroenterol 2000; 35: 123-130.

17. Pillai MR, Nair MK. Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors. Exp Mol Pathol 2000; 69: 233-241.

18. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.

19. Borzacchiello G, Roperto F. Bovine papillomaviruses, papillomas and cancer in cattle. Vet Res 2008; 39: 45.

Acknowledgments

Research supported by Proppi/UFF (2008).

Address for correspondence: S.M.B. Cavalcanti, Laboratório de Diagnóstico Virológico, Departamento de Microbiologia e Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Rua Ernani de Melo, 101, Sala 321, 24210-130 Niterói, RJ, Brasil. E-mail: silviacavalcanti@vm.uff.br

Received October 24, 2009. Accepted May 28, 2010. Available online June 11, 2010. Published July 9, 2010.

The Brazilian Journal of Medical and Biological Research is partially financed by

Publication Dates

History